Ringer solution

DRUG2 trials

Sponsors

Hopital Foch, Negovsky Reanimatology Research Institute

Conditions

Acute Respiratory Distress SyndromeAnesthesia

Phase 3

Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)

WithdrawnNCT04453371

Negovsky Reanimatology Research InstituteAcute Respiratory Distress Syndrome

Start: 2020-10-15End: 2021-02-15Updated: 2021-03-12

Unknown Phase

Validation of Nicom Device to Measure Stoke Volume Variation

TerminatedNCT02485457

Hopital FochAnesthesia

Start: 2015-06-28End: 2017-06-12Updated: 2018-01-29